"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about VERAPAMIL
• Ask Community about VERAPAMIL
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

VERAPAMIL Safety Questions, VERAPAMIL Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about VERAPAMIL. Our extensive database of VERAPAMIL adverse events and VERAPAMIL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about VERAPAMIL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

VERAPAMIL Safety Reports

Total VERAPAMIL reports: 200.
VERAPAMIL FDA safety alerts: No.
Reported deaths: 121    Reported hospitalizations: 45.
Take VERAPAMIL Side Effects Survey or Share Your VERAPAMIL Story. Read More Here.

Showing 1-75 of 200 Next >

Health Professional from SPAIN reported VERAPAMIL problem on Apr 10, 2007. Male patient, 71 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: hypertonia, hypokinesia. VERAPAMIL dosage: 240 MG QD ORAL. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from BRAZIL on Apr 11, 2007. Female patient, 65 years of age, weighting 172.0 lb, was diagnosed with arrhythmia and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, condition aggravated, paraesthesia. VERAPAMIL dosage: (80 MG 1X/12 HOURS ORAL). During the same period patient was treated with ENALAPRIL, GINKO BILOBA, CLONAZEPAM, FOLIC ACID. Patient recovered.

Physician from UNITED STATES reported VERAPAMIL problem on May 03, 2007. Female patient, 58 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, jaundice, liver injury, pruritus. VERAPAMIL dosage: unknown. During the same period patient was treated with PREMARIN, ACIPHEX, VALTREX, AMBIEN, ALLEGRA, ASPIRIN, TYLENOL, BOTOX. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 20, 2007. Female patient, 77 years of age, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, hypotension. VERAPAMIL dosage: (120 MG TID). During the same period patient was treated with LOSARTAN POSTASSIUM, ATORVASTATIN CALCIUM, SPIRONOLACTONE, DOXAZOSIN MESYLATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VERAPAMIL problem on May 03, 2007. Female patient, weighting 139.0 lb, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction. VERAPAMIL dosage: 120 MG ONCE PER DAY PO. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from SPAIN on Apr 20, 2007. Female patient, 77 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. VERAPAMIL dosage: unknown. During the same period patient was treated with DEANXIT, LASIX, PIROXICAM, NSAID, ASPIRIN, ALENDRONATE, CEFUROXIME AXETIL, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/13/2007.

Consumer or non-health professional from UNITED STATES reported VERAPAMIL problem on Apr 16, 2007. Female patient, 61 years of age, weighting 145.0 lb, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, lip swelling, pharyngeal oedema. VERAPAMIL dosage: 180 MG; TWICE A DAY; ORAL. Patient was hospitalized. Patient recovered.

VERAPAMIL problem was reported by a Health Professional from SPAIN on Apr 20, 2007. Male patient, 72 years of age, was diagnosed with cardiomyopathy, hypertension, blood pressure increased and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, haemodialysis, hyperkalaemia, renal failure acute. VERAPAMIL dosage: 240 MG QD ORAL. During the same period patient was treated with ENALAPRIL MALEATE, LASIX, SPIRONOLACTONE, ALOPURINOL, ZARATOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VERAPAMIL problem on Apr 16, 2007. Male patient, weighting 216.0 lb, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: bronchitis, pulmonary congestion, wheezing. VERAPAMIL dosage: unknown. During the same period patient was treated with LISINOPRIL, ZESTRIL, DIOVAN, HYDROCHLOROTHIAZIDE. Patient was hospitalized and became disabled. Patient recovered.

VERAPAMIL problem was reported by a Health Professional from UNITED KINGDOM on Apr 24, 2007. Female patient, 59 years of age, was diagnosed with angina pectoris and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, depression, suicidal ideation. VERAPAMIL dosage: 120 MG QD ORAL. During the same period patient was treated with BENDROFLUMETHIAZIDE. Patient recovered.

Physician from FRANCE reported VERAPAMIL problem on Apr 30, 2007. Female patient, 73 years of age, weighting 158.7 lb, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease, headache, nausea. VERAPAMIL dosage: 240 MG, DAILY, ORAL. During the same period patient was treated with NEO MERCAZOLE, BUDESONIDE W, PIASCLEDINE, TRIMETAZIDINE HYDROCHLORIDE, AZITHROMYCIN. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, 61 years of age, weighting 145.0 lb, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: reaction to colouring. VERAPAMIL dosage: 180 MG; TWICE A DAY; ORAL. During the same period patient was treated with TYLENOL, ALBUTEROL, FLOVENT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported VERAPAMIL problem on May 08, 2007. Male patient, 35 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypotension. VERAPAMIL dosage: unknown. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Female patient, 61 years of age, weighting 145.0 lb, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, face oedema, lip swelling, nasal oedema, pharyngeal oedema, tongue oedema. VERAPAMIL dosage: 180 MG; TWICE A DAY; ORAL. During the same period patient was treated with TYLENOL, ALBUTEROL, FLOVENT, PREVACID, LIPITOR, ALPRAZOLAM, ANACIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported VERAPAMIL problem on June 13, 2007. Female patient, 45 years of age, was diagnosed with intentional overdose and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, bundle branch block left, electrocardiogram qrs complex, electrocardiogram qt prolonged, hypotension. VERAPAMIL dosage: UNIT DOSE: 240 MG. During the same period patient was treated with ASPIRIN. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 11, 2007. Female patient, 72 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac failure congestive, confusional state, decreased appetite, international normalised ratio increased, malaise, nausea, renal failure acute, sepsis. VERAPAMIL dosage: unknown. During the same period patient was treated with WARFARIN, DIGOXIN, METOLAZONE. Patient was hospitalized. Patient died on 07/13/2006.

Consumer or non-health professional from UNITED KINGDOM reported VERAPAMIL problem on June 11, 2007. Female patient, 72 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: confusional state, decreased appetite, nausea, renal failure acute, sepsis, therapeutic agent toxicity, ventricular tachycardia, visual disturbance, vomiting. VERAPAMIL dosage: unknown. During the same period patient was treated with WARFARIN, DIGOXIN, METOLAZONE. Patient was hospitalized. Patient died.

VERAPAMIL problem was reported by a Health Professional from UNITED KINGDOM on June 11, 2007. Female patient, 72 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood electrolytes abnormal, breath sounds abnormal, cardiac failure congestive, confusional state, decreased appetite, international normalised ratio increased. VERAPAMIL dosage: unknown. During the same period patient was treated with WARFARIN, DIGOXIN, METOLAZONE. Patient was hospitalized. Patient died.

Consumer or non-health professional from ITALY reported VERAPAMIL problem on May 08, 2007. Male patient, 35 years of age, was diagnosed with cluster headache and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypotension. VERAPAMIL dosage: (240 MG QD), (360 MG QD). Patient recovered.

VERAPAMIL problem was reported by a Health Professional from UNITED KINGDOM on June 15, 2007. Male patient, 86 years of age, weighting 141.1 lb, was diagnosed with atrial fibrillation and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: asthenia, international normalised ratio increased. VERAPAMIL dosage: unknown. During the same period patient was treated with WARFARIN, PREDNISOLONE, METHOTREXATE, PRAVASTATIN, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VERAPAMIL problem on June 13, 2007. Female patient, 54 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, colon gangrene, ileal gangrene, nodal rhythm, pulse abnormal, somnolence, suicide attempt. VERAPAMIL dosage: unknown. During the same period patient was treated with FIORICET. Patient recovered.

VERAPAMIL problem was reported by a Health Professional from FRANCE on July 04, 2006. Female patient, 52 years of age, weighting 119.0 lb, was diagnosed with hypertension, cystitis, colon cancer and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. VERAPAMIL dosage: unknown. During the same period patient was treated with NOROXIN, FOLINORAL, FLUOROURACILE TEVA, ELOXATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ISRAEL reported VERAPAMIL problem on June 28, 2006. Female patient, 59 years of age, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, hyperglycaemia, intentional overdose, lethargy, metabolic acidosis, nodal rhythm, pleural effusion, pulmonary congestion, renal failure. VERAPAMIL dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, METOPROLOL TARTRATE, DISOTHIAZIDE. Patient was hospitalized. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 62 years of age, was diagnosed with insomnia and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, pyromania. VERAPAMIL dosage: unknown. During the same period patient was treated with ZOLOFT, AMBIEN, NEXIUM. Patient recovered.

Health Professional from FRANCE reported VERAPAMIL problem on July 04, 2006. Female patient, 52 years of age, weighting 119.0 lb, was diagnosed with hypertension, cystitis, colon cancer and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: neutropenia. VERAPAMIL dosage: unknown. During the same period patient was treated with NOROXIN, FOLINORAL, FLUOROURACILE TEVA, ELOXATIN. Patient was hospitalized. Patient recovered.

VERAPAMIL problem was reported by a Health Professional from UNITED STATES on July 28, 2006. Female patient, weighting 200.0 lb, was diagnosed with heart rate increased, hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: blood prolactin increased, galactorrhoea, pituitary tumour. VERAPAMIL dosage: 30MG? ONCE DAILY PO. Patient recovered.

Pharmacist from UNITED STATES reported VERAPAMIL problem on Aug 21, 2006. Female patient was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: contusion. VERAPAMIL dosage: unknown. Patient recovered.

VERAPAMIL problem was reported by a Health Professional from FRANCE on Aug 14, 2006. Male patient, 58 years of age, was diagnosed with hypertension and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block third degree, blood potassium increased, haemodialysis, nodal rhythm, syncope. VERAPAMIL dosage: 240 MG, QD. During the same period patient was treated with AZATHIOPRINE, RAMIPRIL, NICARDIPINE, PRAVASTATIN, CALCIUM CARBONATE, CITRATE, ZOPICLONE, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported VERAPAMIL problem on Aug 14, 2006. Male patient, 57 years of age, was diagnosed with supraventricular tachycardia and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia supraventricular, atrioventricular block third degree, blood potassium increased, syncope. VERAPAMIL dosage: 240 MG, QD. During the same period patient was treated with CALCIUM CARBONATE, ERYTHROPOIETIN. Patient was hospitalized. Patient recovered.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Sept 19, 2006. Male patient, weighting 210.0 lb, was diagnosed with hypertension, ventricular arrhythmia and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, palpitations. VERAPAMIL dosage: 240 MG PO (DURATION: FOUR MONTHS 11 YRS AGO). Patient recovered.

Consumer or non-health professional from UNITED STATES reported VERAPAMIL problem on Oct 03, 2006. Female patient, 82 years of age, was diagnosed with extrasystoles, blood glucose increased and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, balance disorder, blood glucose increased, dizziness, vision blurred. VERAPAMIL dosage: unknown. During the same period patient was treated with STARLIX. Patient recovered.

VERAPAMIL problem was reported by a Health Professional from UNITED STATES on Oct 16, 2006. Female patient, 35 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: bradycardia, dialysis, hypotension, pulmonary oedema. VERAPAMIL dosage: unknown. During the same period patient was treated with NIFEDIPINE, CAPTOPRIL. Patient was hospitalized. Patient recovered.

Health Professional from POLAND reported VERAPAMIL problem on Oct 19, 2006. Male patient, 31 years of age, was diagnosed with renal transplant and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: gingival hyperplasia, gingivitis. VERAPAMIL dosage: unknown. During the same period patient was treated with AMLODIPINE, CORTICOSTEROIDS, CYCLOSPORINE. Patient recovered.

VERAPAMIL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 54 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain lower, blood pressure decreased, bowel sounds abnormal, electrocardiogram abnormal, ileal gangrene, intestinal gangrene, pulse abnormal, somnolence. VERAPAMIL dosage: 1800 MG ONCE PO. During the same period patient was treated with IBUPROFEN, FIORICET. Patient recovered.

Physician from IRELAND reported VERAPAMIL problem on Nov 02, 2006. Male patient was diagnosed with erectile dysfunction and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, epilepsy. VERAPAMIL dosage: 120 MG, UNK. During the same period patient was treated with CIALIS. Patient was hospitalized. Patient recovered.

VERAPAMIL problem was reported by a Physician from AUSTRALIA on Oct 27, 2006. Female patient, 35 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: nodal arrhythmia, overdose, pulmonary oedema. VERAPAMIL dosage: 160 MG. During the same period patient was treated with NIFEDIPINE, CAPTOPRIL. Patient was hospitalized. Patient recovered.

Physician from AUSTRALIA reported VERAPAMIL problem on Oct 30, 2006. Female patient, 70 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, nodal arrhythmia, overdose, pneumonia aspiration, vomiting. VERAPAMIL dosage: 3200 MG. During the same period patient was treated with NORTRIPTYLINE, DIAZEPAM, CODEINE SUL. Patient was hospitalized. Patient died.

VERAPAMIL problem was reported by a Physician from AUSTRALIA on Oct 30, 2006. Female patient, 33 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, loss of consciousness, nodal arrhythmia, overdose. VERAPAMIL dosage: 8000 MG. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient died.

Physician from AUSTRALIA reported VERAPAMIL problem on Oct 30, 2006. Female patient, 64 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: electrocardiogram u-wave abnormality, overdose. VERAPAMIL dosage: 3200 MG, ORAL. Patient was hospitalized. Patient recovered.

VERAPAMIL problem was reported by a Physician from AUSTRALIA on Oct 30, 2006. Female patient, 37 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, nodal arrhythmia, overdose, sinus bradycardia. VERAPAMIL dosage: 8000 MG. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 03, 2006. Female patient, 84 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: accidental overdose. VERAPAMIL dosage: 480 MG, ORAL. During the same period patient was treated with LISINOPRIL. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 03, 2006. Male patient, 28 years of age, was diagnosed with migraine and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, atrioventricular block, incorrect dose administered, overdose, renal failure acute. VERAPAMIL dosage: 480 MG, ORAL. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 03, 2006. Female patient, 64 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: overdose. VERAPAMIL dosage: 360-540 MG, ORAL. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 03, 2006. Male patient was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest neonatal, incorrect dose administered. VERAPAMIL dosage: 25 MG, ONCE/SINGLE, ORAL. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 02, 2006. Male patient, 56 years of age, was diagnosed with chest pain and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: overdose. VERAPAMIL dosage: 2400 MG (TAKEN OVER 3-4 HOURS). Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 02, 2006. Male patient, 28 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cardiac disorder, chest pain, incorrect dose administered, renal failure acute. VERAPAMIL dosage: 480 MG (240 MG), ORAL. During the same period patient was treated with COCAINE. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 02, 2006. Female patient, 84 years of age, was treated with VERAPAMIL. VERAPAMIL dosage: 480 MG, ORAL. During the same period patient was treated with LISINOPRIL. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 02, 2006. Male patient was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, cardio-respiratory arrest neonatal. VERAPAMIL dosage: 25 MG (25 MG), ORAL. Patient died.

Health Professional from UNITED STATES reported VERAPAMIL problem on Nov 03, 2006. Male patient, 56 years of age, was diagnosed with chest pain and was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: overdose. VERAPAMIL dosage: 2400 MG OVER 3-4 HOUR ORAL. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 02, 2006. Female patient, 58 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. VERAPAMIL dosage: 2400 MG (240 MG), ORAL. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 02, 2006. Female patient, 64 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. VERAPAMIL dosage: 360-540 MG (180 MG), ORAL. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 50 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. VERAPAMIL dosage: unknown. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Oct 24, 2006. Female patient, 33 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, poisoning, respiratory arrest. VERAPAMIL dosage: unknown. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 23 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. VERAPAMIL dosage: unknown. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Oct 24, 2006. Female patient, 65 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. VERAPAMIL dosage: unknown. During the same period patient was treated with ASPIRIN. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 91 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: poisoning. VERAPAMIL dosage: unknown. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Oct 24, 2006. Female patient, 89 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: poisoning. VERAPAMIL dosage: unknown. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 82 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. VERAPAMIL dosage: unknown. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 03, 2006. Male patient, 68 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, bradycardia, overdose. VERAPAMIL dosage: 1000 MG OVER A DAY, ORAL. Patient recovered.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 03, 2006. Female patient, 69 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, hypotension. VERAPAMIL dosage: 640 MG, ORAL. Patient recovered.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 03, 2006. Female patient, 58 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypotension. VERAPAMIL dosage: 1080 MG, ORAL. Patient recovered.

VERAPAMIL problem was reported by a Physician from AUSTRALIA on Oct 30, 2006. Female patient, 37 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, nodal arrhythmia, overdose, sinus bradycardia. VERAPAMIL dosage: 8000 MG. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 47 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. VERAPAMIL dosage: unknown. During the same period patient was treated with DULOXETINE HYDROCHLORIDE, CYCLOBENZAPRINE. Patient died on 01/01/2006.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 81 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with DIGOXIN, CLOPIDOGREL. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 87 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with MEMANTINE. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 50 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 39 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with ALPRAZOLAM, NORTRIPTYLINE. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 50 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 50 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient died.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 46 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, VALPROIC ACID. Patient died.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 45 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with TOPIRAMATE. Patient died on 01/01/2005.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 62 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. VERAPAMIL dosage: unknown. Patient died on 01/01/2005.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 69 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, QUETIAPINE FUMARATE. Patient died on 01/01/2005.

VERAPAMIL problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 83 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: completed suicide. VERAPAMIL dosage: unknown. During the same period patient was treated with SERTRALINE, TRAZODONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported VERAPAMIL problem on Nov 09, 2006. Female patient, 45 years of age, was treated with VERAPAMIL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. VERAPAMIL dosage: unknown. Patient died.

Showing 1-75 of 200 Next >

Ask Our Patient Community about VERAPAMIL
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam)